Consort Medical plc announced the appointment of Chris Brinsmead CBE as a nonexecutive director and Chairman designate. Chris will join the Board on 7 February 2019 and will succeed Dr. Peter Fellner as Chairman on 24 April 2019. Peter will step down from the Board on the same date; his intention to step down was announced on 14 June 2018. Andrew Jackson was appointed as General Counsel and Company Secretary in August 2018, joining from his previous role as Group Counsel at KP Snacks Limited. Andrew replaces Iain Lindsay, Interim General Counsel.

The Board has increased the interim dividend per share by 2.2% to 7.60 pence (first half of fiscal year 2018: 7.44 pence). Payment will be on 15 February 2019 to holders on the register on the record date of 18 January 2019.